These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 36803109)
41. Exogenous Insulin Infusion Can Decrease Atherosclerosis in Diabetic Rodents by Improving Lipids, Inflammation, and Endothelial Function. Park K; Li Q; Evcimen ND; Rask-Madsen C; Maeda Y; Maddaloni E; Yokomizo H; Shinjo T; St-Louis R; Fu J; Gordin D; Khamaisi M; Pober D; Keenan H; King GL Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):92-101. PubMed ID: 29162603 [TBL] [Abstract][Full Text] [Related]
42. METTL3 (Methyltransferase Like 3)-Dependent N6-Methyladenosine Modification on Li Q; Yu L; Gao A; Ren R; Zhang J; Cao L; Wang X; Liu Y; Qi W; Cai L; Li W; Wang W; Guo X; Su G; Yu X; Zhang J; Xi B; Zhang Y; Zhang M; Zhang C Arterioscler Thromb Vasc Biol; 2023 May; 43(5):755-773. PubMed ID: 36951060 [TBL] [Abstract][Full Text] [Related]
44. KLF7 Alleviates Atherosclerotic Lesions and Inhibits Glucose Metabolic Reprogramming in Macrophages by Regulating HDAC4/miR-148b-3p/NCOR1. Chen F; Li J; Zheng T; Chen T; Yuan Z Gerontology; 2022; 68(11):1291-1310. PubMed ID: 35439761 [TBL] [Abstract][Full Text] [Related]
45. Immunization with advanced glycation end products modified low density lipoprotein inhibits atherosclerosis progression in diabetic apoE and LDLR null mice. Zhu L; He Z; Wu F; Ding R; Jiang Q; Zhang J; Fan M; Wang X; Eva B; Jan N; Liang C; Wu Z Cardiovasc Diabetol; 2014 Nov; 13():151. PubMed ID: 25391642 [TBL] [Abstract][Full Text] [Related]
46. Inclisiran inhibits oxidized low-density lipoprotein-induced foam cell formation in Raw264.7 macrophages via activating the PPARγ pathway. Wang Z; Chen X; Liu J; Wang Y; Zhang S Autoimmunity; 2022 Jun; 55(4):223-232. PubMed ID: 35289693 [TBL] [Abstract][Full Text] [Related]
47. MicroRNA-27 Prevents Atherosclerosis by Suppressing Lipoprotein Lipase-Induced Lipid Accumulation and Inflammatory Response in Apolipoprotein E Knockout Mice. Xie W; Li L; Zhang M; Cheng HP; Gong D; Lv YC; Yao F; He PP; Ouyang XP; Lan G; Liu D; Zhao ZW; Tan YL; Zheng XL; Yin WD; Tang CK PLoS One; 2016; 11(6):e0157085. PubMed ID: 27257686 [TBL] [Abstract][Full Text] [Related]
48. Rutaecarpine derivative R3 attenuates atherosclerosis via inhibiting NLRP3 inflammasome-related inflammation and modulating cholesterol transport. Luo J; Wang X; Jiang X; Liu C; Li Y; Han X; Zuo X; Li Y; Li N; Xu Y; Si S FASEB J; 2020 Jan; 34(1):1398-1411. PubMed ID: 31914630 [TBL] [Abstract][Full Text] [Related]
49. Trimethylamine N-oxide promotes atherosclerosis via CD36-dependent MAPK/JNK pathway. Geng J; Yang C; Wang B; Zhang X; Hu T; Gu Y; Li J Biomed Pharmacother; 2018 Jan; 97():941-947. PubMed ID: 29136772 [TBL] [Abstract][Full Text] [Related]
50. Araloside C attenuates atherosclerosis by modulating macrophage polarization via Sirt1-mediated autophagy. Luo Y; Lu S; Gao Y; Yang K; Wu D; Xu X; Sun G; Sun X Aging (Albany NY); 2020 Jan; 12(2):1704-1724. PubMed ID: 31986489 [TBL] [Abstract][Full Text] [Related]
52. Kuwanon G attenuates atherosclerosis by upregulation of LXRα-ABCA1/ABCG1 and inhibition of NFκB activity in macrophages. Liu XX; Zhang XW; Wang K; Wang XY; Ma WL; Cao W; Mo D; Sun Y; Li XQ Toxicol Appl Pharmacol; 2018 Feb; 341():56-63. PubMed ID: 29355567 [TBL] [Abstract][Full Text] [Related]
53. Impact of glutathione peroxidase-1 deficiency on macrophage foam cell formation and proliferation: implications for atherogenesis. Cheng F; Torzewski M; Degreif A; Rossmann H; Canisius A; Lackner KJ PLoS One; 2013; 8(8):e72063. PubMed ID: 23991041 [TBL] [Abstract][Full Text] [Related]
54. Pim-2 kinase inhibits inflammation by suppressing the mTORC1 pathway in atherosclerosis. Liao M; Hu F; Qiu Z; Li J; Huang C; Xu Y; Cheng X Aging (Albany NY); 2021 Sep; 13(18):22412-22431. PubMed ID: 34547720 [TBL] [Abstract][Full Text] [Related]
55. DBZ (Danshensu Bingpian Zhi), a Novel Natural Compound Derivative, Attenuates Atherosclerosis in Apolipoprotein E-Deficient Mice. Wang J; Xu P; Xie X; Li J; Zhang J; Wang J; Hong F; Li J; Zhang Y; Song Y; Zheng X; Zhai Y J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 28971954 [TBL] [Abstract][Full Text] [Related]
56. Type 1 diabetes increases retention of low-density lipoprotein in the atherosclerosis-prone area of the murine aorta. Hagensen MK; Mortensen MB; Kjolby M; Stillits NL; Steffensen LB; Bentzon JF Atherosclerosis; 2017 Aug; 263():7-14. PubMed ID: 28550710 [TBL] [Abstract][Full Text] [Related]
57. Nε-carboxymethyl-lysine-induced PI3K/Akt signaling inhibition promotes foam cell apoptosis and atherosclerosis progression. Wang Z; Bao Z; Ding Y; Xu S; Du R; Yan J; Li L; Sun Z; Shao C; Gu W Biomed Pharmacother; 2019 Jul; 115():108880. PubMed ID: 31035012 [TBL] [Abstract][Full Text] [Related]
58. RIP140 contributes to foam cell formation and atherosclerosis by regulating cholesterol homeostasis in macrophages. Lin YW; Liu PS; Adhikari N; Hall JL; Wei LN J Mol Cell Cardiol; 2015 Feb; 79():287-94. PubMed ID: 25528964 [TBL] [Abstract][Full Text] [Related]
59. PKM2-dependent metabolic reprogramming in CD4 Lü S; Deng J; Liu H; Liu B; Yang J; Miao Y; Li J; Wang N; Jiang C; Xu Q; Wang X; Feng J J Mol Med (Berl); 2018 Jun; 96(6):585-600. PubMed ID: 29732501 [TBL] [Abstract][Full Text] [Related]
60. New role of PCSK9 in atherosclerotic inflammation promotion involving the TLR4/NF-κB pathway. Tang ZH; Peng J; Ren Z; Yang J; Li TT; Li TH; Wang Z; Wei DH; Liu LS; Zheng XL; Jiang ZS Atherosclerosis; 2017 Jul; 262():113-122. PubMed ID: 28535426 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]